These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 27273809)

  • 1. Preparing a prescription drug monitoring program data set for research purposes.
    O'Kane N; Hallvik SE; Marino M; Van Otterloo J; Hildebran C; Leichtling G; Deyo RA
    Pharmacoepidemiol Drug Saf; 2016 Sep; 25(9):993-7. PubMed ID: 27273809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of state prescription drug monitoring programs: a state-by-state survey.
    Manasco AT; Griggs C; Leeds R; Langlois BK; Breaud AH; Mitchell PM; Weiner SG
    Pharmacoepidemiol Drug Saf; 2016 Jul; 25(7):847-51. PubMed ID: 27061342
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Florida's Prescription Drug Monitoring Program and Pill Mill Laws on Opioid Prescribing and Use.
    Rutkow L; Chang HY; Daubresse M; Webster DW; Stuart EA; Alexander GC
    JAMA Intern Med; 2015 Oct; 175(10):1642-9. PubMed ID: 26280092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacists' training, perceived roles, and actions associated with dispensing controlled substance prescriptions.
    Fleming ML; Barner JC; Brown CM; Shepherd MD; Strassels SA; Novak S
    J Am Pharm Assoc (2003); 2014; 54(3):241-50. PubMed ID: 24816350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Florida's prescription drug monitoring program and pill mill law on high-risk patients: A comparative interrupted time series analysis.
    Chang HY; Murimi I; Faul M; Rutkow L; Alexander GC
    Pharmacoepidemiol Drug Saf; 2018 Apr; 27(4):422-429. PubMed ID: 29488663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Supply of Prescription Opioids: Contributions of Episodic-Care Prescribers and High-Quantity Prescribers.
    Schneberk T; Raffetto B; Kim D; Schriger DL
    Ann Emerg Med; 2018 Jun; 71(6):668-673.e3. PubMed ID: 29275945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unsolicited Reporting to Prescribers of Opioid Analgesics by a State Prescription Drug Monitoring Program: An Observational Study with Matched Comparison Group.
    Young LD; Kreiner PW; Panas L
    Pain Med; 2018 Jul; 19(7):1396-1407. PubMed ID: 28383713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of North Carolina's prescription drug monitoring program on the prescribing behaviors of the state's providers.
    Ringwalt C; Garrettson M; Alexandridis A
    J Prim Prev; 2015 Apr; 36(2):131-7. PubMed ID: 25466768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Prescription Drug Monitoring Program Use With Opioid Prescribing and Health Outcomes: A Comparison of Program Users and Nonusers.
    Deyo RA; Hallvik SE; Hildebran C; Marino M; Springer R; Irvine JM; O'Kane N; Van Otterloo J; Wright DA; Leichtling G; Millet LM; Carson J; Wakeland W; McCarty D
    J Pain; 2018 Feb; 19(2):166-177. PubMed ID: 29054493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Effect of Online Prescription Drug Monitoring on Opioid Prescription Habits After Elective Single-level Lumbar Fusion.
    Siegel N; Lambrechts MJ; Minetos P; Karamian BA; Nourie B; Curran J; Wang J; Canseco JA; Woods BI; Kaye D; Hilibrand AS; Kepler CK; Vaccaro AR; Schroeder GD
    J Am Acad Orthop Surg; 2022 Nov; 30(21):e1411-e1418. PubMed ID: 35947832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implementing real-time prescription drug monitoring: are we ready?
    Nielsen S; Bruno R
    Drug Alcohol Rev; 2014 Sep; 33(5):463-5. PubMed ID: 25186192
    [No Abstract]   [Full Text] [Related]  

  • 13. Disclosure of Use and Abuse of Controlled Substances Among Psychiatric Outpatients.
    De Marco Centeno P; Baig M; Lee SE; Lane CJ; Lagomasino IT
    J Psychiatr Pract; 2015 Nov; 21(6):412-8. PubMed ID: 26554323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in Medical Use of Opioids in the U.S., 2006-2016.
    Piper BJ; Shah DT; Simoyan OM; McCall KL; Nichols SD
    Am J Prev Med; 2018 May; 54(5):652-660. PubMed ID: 29551331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of prescription drug monitoring programs (PDMPs) on opioid utilization among Medicare beneficiaries in 10 US States.
    Moyo P; Simoni-Wastila L; Griffin BA; Onukwugha E; Harrington D; Alexander GC; Palumbo F
    Addiction; 2017 Oct; 112(10):1784-1796. PubMed ID: 28498498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Responsible, Safe, and Effective Prescription of Opioids for Chronic Non-Cancer Pain: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
    Manchikanti L; Kaye AM; Knezevic NN; McAnally H; Slavin K; Trescot AM; Blank S; Pampati V; Abdi S; Grider JS; Kaye AD; Manchikanti KN; Cordner H; Gharibo CG; Harned ME; Albers SL; Atluri S; Aydin SM; Bakshi S; Barkin RL; Benyamin RM; Boswell MV; Buenaventura RM; Calodney AK; Cedeno DL; Datta S; Deer TR; Fellows B; Galan V; Grami V; Hansen H; Helm Ii S; Justiz R; Koyyalagunta D; Malla Y; Navani A; Nouri KH; Pasupuleti R; Sehgal N; Silverman SM; Simopoulos TT; Singh V; Solanki DR; Staats PS; Vallejo R; Wargo BW; Watanabe A; Hirsch JA
    Pain Physician; 2017 Feb; 20(2S):S3-S92. PubMed ID: 28226332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Understanding multi-pill ingestion of prescription opioids: Prevalence, characteristics, and motivation.
    Ellis MS; Cicero TJ; Dart RC; Green JL
    Pharmacoepidemiol Drug Saf; 2019 Jan; 28(1):117-121. PubMed ID: 30411819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescription drug monitoring and dispensing of prescription opioids.
    Brady JE; Wunsch H; DiMaggio C; Lang BH; Giglio J; Li G
    Public Health Rep; 2014; 129(2):139-47. PubMed ID: 24587548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in misuse and abuse of prescription opioids following implementation of Extended-Release and Long-Acting Opioid Analgesic Risk Evaluation and Mitigation Strategy.
    Bucher Bartelson B; Le Lait MC; Green JL; Cepeda MS; Coplan PM; Maziere JY; Wedin GP; Dart RC
    Pharmacoepidemiol Drug Saf; 2017 Sep; 26(9):1061-1070. PubMed ID: 28758289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doctor hopping and doctor shopping for prescription opioids associated with increased odds of high-risk use.
    Young SG; Hayes CJ; Aram J; Tait MA
    Pharmacoepidemiol Drug Saf; 2019 Aug; 28(8):1117-1124. PubMed ID: 31168860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.